IP Library › Granted Patent US 12,471,850
Granted Patent B2
US 12,471,850 · App. 16/744,488 · Granted Nov 18, 2025

Methods of lag-compensation for analyte measurements, and devices related thereto

Inventors: Erwin S. Budiman (Fremont, CA); David L. Li (Fullerton, CA)
Assignee: ABBOTT DIABETES CARE INC.
A61B5/7221A61B5/14532A61B5/7203A61B5/742
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,471,850
App. No.
16/744,488
Granted
Nov 18, 2025
Kind
B2
Abstract

Methods comprising applying a first analyte point measurement filter comprising: receiving, from an in vivo analyte sensor, at least a first, second, and third uncompensated analyte measurement at a first, second and third reference time; determining a first scaled rate-of-change by multiplying a first weighting coefficient and a first rate-of-change, the first rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the second uncompensated analyte measurement at the first prior reference time; determining a second scaled rate-of-change by multiplying a second weighting coefficient and a second rate-of-change, the second rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the third uncompensated analyte measurement at the second prior reference time; and calculating a first filter lag-compensated point measurement based on the sum of the first uncompensated analyte measurement, the first scaled rate-of-change, and the second scaled rate-of-change.

Claims (134)

1 . A method of determining a level of an analyte in a bodily fluid with an analyte monitoring system comprising an in vivo analyte sensor and an analyte monitoring device, which monitor analyte over a period of time, the method comprising:

determining, by one or more processors of the analyte monitoring system, a combination of time delays, the combination of time delays including a first time delay and a second time delay, wherein determining the combination of time delays comprises:

defining a search space;

evaluating a plurality of candidate combination of time delays within the search space based on an evaluation function; and

selecting, based on the evaluation function, the first time delay and the second time delay for the combination of time delays;

sensing, by the in vivo analyte sensor that is in contact with interstitial fluid of a subject, a first uncompensated analyte measurement, a second uncompensated analyte measurement, a third uncompensated analyte measurement, wherein the first uncompensated analyte measurement is associated with a lag corresponding to analyte measurements sensed in the interstitial fluid relative to measurements sensed in blood, wherein the first uncompensated analyte measurement is sensed at a first initial reference time, wherein the second analyte measurement and the third analyte measurement are sensed at prior time points corresponding to a first prior reference time for the second analyte measurement and a second prior reference time for the third analyte measurement, wherein the first prior reference time corresponds to the first time delay and the second prior reference time corresponds to the second time delay;

receiving, by the analyte monitoring device, the first uncompensated analyte measurement, the second uncompensated analyte measure, and the third uncompensated analyte measurement;

applying, by the analyte monitoring device, a first analyte point measurement filter by:

determining a first scaled rate-of-change by multiplying a first weighting coefficient and a first rate-of-change, the first rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the second uncompensated analyte measurement at the first prior reference time;

determining a second scaled rate-of-change by multiplying a second weighting coefficient and a second rate-of-change, the second rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the third uncompensated analyte measurement at the second prior reference time; and

calculating a first filter lag-compensated point measurement based on the first uncompensated analyte measurement, the first scaled rate-of-change, and the second scaled rate-of-change; and

determining, by the analyte monitoring device, an estimated blood analyte level of the subject at the first initial reference time by using the first filter lag-compensated point measurement calculated based on the first uncompensated analyte measurement sensed in the interstitial fluid, wherein the estimated blood analyte level compensates for the lag corresponding to analyte measurements sensed in the interstitial fluid relative to measurements sensed in blood;

displaying, by the analyte monitoring device, a representation of the estimated blood analyte level at the first initial reference time.

2 . The method of claim 1 , wherein the in vivo analyte sensor detects glucose.

3 . The method of claim 1 , further comprising calculating a first filter lag-compensated rate-of-change analyte measurement based on a sum of the first scaled rate-of-change and the second scaled rate-of-change.

4 . The method of claim 1 , further comprising:

determining a first filter scaled lag-compensated analyte point measurement by multiplying a first filter point weighting coefficient and the first filter lag-compensated analyte point measurement;

receiving, from the in vivo analyte sensor, at least a fourth uncompensated analyte measurement at a fourth prior reference time relative to the first initial reference time, and a fifth uncompensated analyte measurement at a fifth prior reference time relative to the first initial reference time;

applying at least a second analyte point measurement filter by:

determining a third scaled rate-of-change by multiplying a third weighting coefficient and a third rate-of-change, the third rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the fourth uncompensated analyte measurement at the fourth prior reference time; determining a fourth scaled rate-of-change by multiplying a fourth weighting coefficient and a fourth rate-of-change, the fourth rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the fifth uncompensated analyte measurement at the fifth prior reference time;

calculating a second filter lag-compensated analyte point measurement based on a sum of the first uncompensated analyte measurement, the third scaled rate-of-change, and the fourth scaled rate-of-change; and

determining a second filter scaled lag-compensated analyte point measurement by multiplying a second filter point weighting coefficient and the second filter lag-compensated analyte point measurement; and

calculating a first bank lag-compensated analyte point measurement based on the sum of the first filter scaled lag-compensated analyte point measurement and the second filter scaled lag-compensated analyte measurement.

5 . The method of claim 4 , further comprising:

calculating a first filter lag-compensated analyte rate-of-change measurement based on the sum of the first scaled rate-of-change and the second scaled rate-of-change;

determining a first filter scaled lag-compensated analyte rate-of-change measurement by multiplying a first filter rate-of-change weighting coefficient and the first filter lag-compensated analyte rate-of-change measurement;

calculating a second filter lag-compensated analyte rate-of-change measurement based on the sum of the third scaled rate-of-change and the fourth scaled rate-of-change;

determining a second filter scaled lag-compensated analyte rate-of-change measurement by multiplying a second filter rate-of-change weighting coefficient and the second filter lag-compensated analyte rate-of-change measurement; and

calculating a lag-compensated rate-of-change analyte measurement based on the sum of the first filter scaled analyte rate-of-change measurement and the second filter scaled analyte rate-of-change measurement.

6 . The method of claim 1 , further comprising:

determining a first filter scaled lag-compensated analyte point measurement by multiplying a first filter point weighting coefficient and the first filter lag-compensated analyte point measurement;

receiving, from the in vivo analyte sensor, at least a fourth uncompensated analyte measurement at a fourth prior reference time relative to the first initial reference time, and a fifth uncompensated analyte measurement at a fifth prior reference time relative to the first initial reference time;

applying a second analyte point measurement filter by:

determining a third scaled rate-of-change by multiplying a third weighting coefficient and a third rate-of-change, the third rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the fourth uncompensated analyte measurement at the fourth prior reference time;

determining a fourth scaled rate-of-change by multiplying a fourth weighting coefficient and a fourth rate-of-change, the fourth rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the fifth uncompensated analyte measurement at the fifth prior reference time;

calculating a second filter lag-compensated analyte point measurement based on a sum of the first uncompensated analyte measurement, the third scaled rate-of-change, and the fourth scaled rate-of-change; and

determining a second filter scaled lag-compensated analyte point measurement by multiplying a second filter point weighting coefficient and the second filter lag-compensated analyte point measurement;

receiving, from the in vivo analyte sensor, at least a sixth uncompensated analyte measurement at a sixth prior reference time relative to the first initial reference time, and a seventh uncompensated analyte measurement at a seventh prior reference time relative to the first initial reference time;

applying at least a third analyte point measurement filter by:

determining a fifth scaled rate-of-change by multiplying a fifth weighting coefficient and a fifth rate-of-change, the fifth rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the sixth uncompensated analyte measurement at the sixth prior reference time;

determining a sixth scaled rate-of-change by multiplying a sixth weighting coefficient and a sixth rate-of-change, the sixth rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the seventh uncompensated analyte measurement at the seventh prior reference time;

calculating a third filter lag-compensated analyte point measurement based on the sum of the first uncompensated analyte measurement, the fifth scaled rate-of-change, and the sixth scaled rate-of-change; and

determining a third filter scaled lag-compensated analyte point measurement by multiplying a third filter point weighting coefficient and the third filter lag-compensated analyte point measurement; and

calculating a first bank lag-compensated analyte point measurement based on the sum of the first filter scaled lag-compensated analyte point measurement, the second filter scaled lag-compensated analyte point measurement, and the third filter scaled lag-compensated analyte point measurement.

7 . The method of claim 6 , further comprising:

calculating a first filter lag-compensated analyte rate-of-change measurement based on the sum of the first scaled rate-of-change and the second scaled rate-of-change;

determining a first filter scaled lag-compensated analyte rate-of-change measurement by multiplying a first filter rate-of-change weighting coefficient and the first filter lag-compensated analyte rate-of-change measurement;

calculating a second filter lag-compensated analyte rate-of-change measurement based on the sum of the third scaled rate-of-change and the fourth scaled rate-of-change;

determining a second filter scaled lag-compensated analyte rate-of-change measurement by multiplying a second filter rate-of-change weighting coefficient and the second filter lag-compensated analyte rate-of-change measurement;

calculating a third filter lag-compensated analyte rate-of-change measurement based on the sum of the fifth scaled rate-of-change and the sixth scaled rate-of-change; and

determining a third filter scaled lag-compensated analyte rate-of-change measurement by multiplying a third filter rate-of-change weighting coefficient and the third filter lag-compensated analyte rate-of-change measurement; and

calculating a lag-compensated rate-of-change analyte measurement based on the sum of the first filter scaled analyte rate-of-change measurement, the second filter scaled analyte rate-of-change measurement, and the third filter scaled analyte rate-of-change measurement.

8 . The method of claim 6 , further comprising:

receiving, from the in vivo analyte sensor, at least an eighth uncompensated analyte measurement at a second initial reference time that is prior to the first initial reference time, a ninth uncompensated analyte measurement at an eighth prior reference time, and a tenth uncompensated analyte measurement at a ninth prior reference time,

wherein the eight prior reference time and the ninth prior reference time are relative to the second initial reference time;

calculating at least a second bank lag-compensated analyte point measurement by applying at least a fourth analyte point measurement filter by:

determining a seventh scaled rate-of-change by multiplying a seventh weighting coefficient and a seventh rate-of-change, the seventh rate-of-change computed between the eighth uncompensated analyte measurement at the second initial reference time to the ninth uncompensated analyte measurement at the eighth prior reference time;

determining an eighth scaled rate-of-change by multiplying an eighth weighting coefficient and an eighth rate-of-change, the eighth rate-of-change computed between the eighth uncompensated analyte measurement at the second initial reference time to the tenth uncompensated analyte measurement at the ninth prior reference time; and

calculating a fourth filter lag-compensated analyte point measurement based on the sum of the eighth uncompensated analyte measurement, the seventh scaled rate-of-change, and the eighth scaled rate-of-change.

9 . The method of claim 8 , further comprising:

determining a weighted first bank lag-compensated analyte point measurement by multiplying the first bank lag-compensated analyte point measurement by a first discrepancy weighting agent;

determining a weighted second bank lag-compensated analyte point measurement by multiplying the fourth filter lag-compensated analyte point measurement by a second discrepancy weighting agent,

wherein the first discrepancy weighting agent and the second discrepancy weighting agent are based on a severity of discrepancy between the first bank lag-compensated analyte point measurement and the fourth filter lag-compensated analyte point measurement; and

calculating a resulting lag-compensated analyte point measurement based on the sum of the weighted first bank lag-compensated analyte point measurement and the weighted second bank lag-compensated analyte point measurement.

10 . The method of claim 8 , further comprising:

determining a fourth filter scaled lag-compensated analyte point measurement by multiplying a fourth filter point weighting coefficient and the fourth filter lag-compensated analyte point measurement;

receiving, from the in vivo analyte sensor, at least an eleventh uncompensated analyte measurement at a tenth prior reference time, and a twelfth uncompensated analyte measurement at an eleventh prior reference time,

wherein the tenth prior reference time and the eleventh prior reference time are relative to the second initial reference time;

calculating the second bank lag-compensated analyte point measurement by applying at least a fifth analyte point measurement filter, the fifth analyte point measurement filter comprising:

determining a ninth scaled rate-of-change by multiplying a ninth weighting coefficient and a ninth rate-of-change, the ninth rate-of-change computed between the eighth uncompensated analyte measurement at the second initial reference time to the eleventh uncompensated analyte measurement at the tenth prior reference time;

determining a tenth scaled rate-of-change by multiplying a tenth weighting coefficient and a tenth rate-of-change, the tenth rate-of-change computed between the eighth uncompensated analyte measurement at the second initial reference time to the twelfth uncompensated analyte measurement at the tenth prior reference time;

calculating a fifth filter lag-compensated analyte point measurement based on the sum of the eighth uncompensated analyte measurement, the ninth scaled rate-of-change, and the tenth scaled rate-of-change; and

determining a fifth filter scaled lag-compensated analyte point measurement by multiplying a fifth filter point weighting coefficient and the fifth filter lag-compensated analyte point measurement; and

calculating the second bank lag-compensated analyte point measurement based on the sum of the fourth filter scaled lag-compensated analyte point measurement and the fifth filter scaled lag-compensated analyte point measurement.

11 . The method of claim 10 , further comprising:

determining a weighted first bank lag-compensated analyte point measurement by multiplying the first bank lag-compensated analyte point measurement by a first discrepancy weighting agent;

determining a weighted second bank lag-compensated analyte point measurement by multiplying the second bank lag-compensated analyte point measurement by a second discrepancy weighting agent,

wherein the first discrepancy weighting agent and the second discrepancy weighting agent are based on a severity of discrepancy between the first bank lag-compensated analyte point measurement and the second bank lag-compensated analyte point measurement; and

calculating a resulting lag-compensated analyte point measurement based on the sum of the weighted first bank lag-compensated analyte point measurement and the weighted second bank lag-compensated analyte point measurement.

12 . The method of claim 8 , further comprising:

determining a fourth filter scaled lag-compensated analyte point measurement by multiplying a fourth filter point weighting coefficient and the fourth filter lag-compensated analyte point measurement;

receiving, from the in vivo analyte sensor, at least an eleventh uncompensated analyte measurement at a tenth prior reference time, and a twelfth uncompensated analyte measurement at an eleventh prior reference time,

wherein the tenth prior reference time and the eleventh prior reference time are relative to the second initial reference time;

calculating the second bank lag-compensated analyte point measurement comprising:

applying a fifth analyte point measurement filter by:

determining a ninth scaled rate-of-change by multiplying a ninth weighting coefficient and a ninth rate-of-change, the ninth rate-of-change computed between the eighth uncompensated analyte measurement at the second initial reference time to the eleventh uncompensated analyte measurement at the tenth prior reference time;

determining a tenth scaled rate-of-change by multiplying a tenth weighting coefficient and a tenth rate-of-change, the tenth rate-of-change computed between the eighth uncompensated analyte measurement at the second initial reference time to the twelfth uncompensated analyte measurement at the tenth prior reference time;

calculating a fifth filter lag-compensated analyte point measurement based on the sum of the eighth uncompensated analyte measurement, the ninth scaled rate-of-change, and the tenth scaled rate-of-change; and

determining a fifth filter scaled lag-compensated analyte point measurement by multiplying a fifth filter point weighting coefficient and the fifth filter lag-compensated analyte point measurement;

receiving, from the in vivo analyte sensor, at least a thirteenth uncompensated analyte measurement at a twelfth prior reference time, and a fourteenth uncompensated analyte measurement at a thirteenth prior reference time,

wherein the twelfth prior reference time and the thirteenth prior reference time are relative to the second initial reference time;

applying at least a sixth analyte point measurement filter by:

determining an eleventh scaled rate-of-change by multiplying an eleventh weighting coefficient and an eleventh rate-of-change, the eleventh rate-of-change computed between the eighth uncompensated analyte measurement at the second initial reference time to the thirteenth uncompensated analyte measurement at the twelfth prior reference time;

determining a twelfth scaled rate-of-change by multiplying a twelfth weighting coefficient and a twelfth rate-of-change, the twelfth rate-of-change computed between the eighth uncompensated analyte measurement at the second initial reference time to the fourteenth uncompensated analyte measurement at the thirteenth prior reference time;

calculating a sixth filter lag-compensated analyte point measurement based on the sum of the eighth uncompensated analyte measurement, the eleventh scaled rate-of-change, and the twelfth scaled rate-of-change; and

determining a sixth filter scaled lag-compensated analyte point measurement by multiplying a sixth filter point weighting coefficient and the sixth filter lag-compensated analyte point measurement; and

calculating the second bank lag-compensated analyte point measurement based on the sum of the fourth filter scaled lag-compensated analyte point measurement, the fifth filter scaled lag-compensated analyte point measurement, and the sixth filter scaled lag-compensated analyte point measurement.

13 . The method of claim 12 , further comprising:

determining a weighted first bank lag-compensated analyte point measurement by multiplying the first bank lag-compensated analyte point measurement by a first discrepancy weighting agent;

determining a weighted second bank lag-compensated analyte point measurement by multiplying the second bank lag-compensated analyte point measurement by a second discrepancy weighting agent,

wherein the first discrepancy weighting agent and the second discrepancy weighting agent are based on a severity of discrepancy between the first bank lag-compensated analyte point measurement and the second bank lag-compensated analyte point measurement; and

calculating a resulting lag-compensated analyte point measurement based on the sum of the weighted first bank lag-compensated analyte point measurement and the weighted second bank lag-compensated analyte point measurement.

14 . The method of claim 1 , wherein displaying the representation of the estimated blood analyte level comprises displaying the first filter lag-compensated point measurement.

15 . The method of claim 1 , further comprising activating an alarm system based on the first filter lag-compensated point measurement.

16 . The method of claim 1 , further comprising adjusting an administered dose of a medication via a medication delivery system.

17 . An analyte monitoring system comprising:

an in vivo analyte sensor comprising a first portion configured to be positioned beneath a skin surface of a user and in contact with interstitial fluid and a second portion configured to be operatively coupled to a data processing unit, wherein the in vivo analyte sensor is configured to be in contact with the interstitial fluid of a subject, wherein the in vivo analyte sensor is configured to monitor analyte over a period of time and perform operations comprising:

determining, by one or more processors of the analyte monitoring system, a combination of time delays, the combination of time delays including a first time delay and a second time delay, wherein determining the combination of time delays comprises:

defining a search space;

evaluating a plurality of candidate combination of time delays within the search space based on an evaluation function; and

selecting, based on the evaluation function, the first time delay and the second time delay for the combination of time delays;

sensing a first uncompensated analyte measurement, a second uncompensated analyte measurement, a third uncompensated analyte measurement, wherein the first uncompensated analyte measurement is associated with a lag corresponding to analyte measurements sensed in the interstitial fluid relative to measurements sensed in blood, wherein the first uncompensated analyte measurement is sensed at a first initial reference time, wherein the second analyte measurement and the third analyte measurement are sensed at prior time points corresponding to a first prior reference time for the second analyte measurement and a second prior reference time for the third analyte measurement, wherein the first prior reference time corresponds to the first time delay and the second prior reference time corresponds to the second time delay;

a data processing unit comprising a processor, a transmitter, and a memory operatively coupled to the processor; and

an analyte monitoring device comprising a processor, a receiver, and a memory operatively coupled to the processor, wherein the memory of the data processing unit or the memory of the analyte monitoring device comprise instructions that, when executed by the processor of the data processing unit or the analyte monitoring device, respectively, are configured to cause the respective processor to perform operations comprising:

receiving, from the in vivo analyte sensor, the first uncompensated analyte measurement, the second uncompensated analyte measure, and the third uncompensated analyte measurement;

applying a first analyte point measurement filter by:

determining a first scaled rate-of-change by multiplying a first weighting coefficient and a first rate-of-change, the first rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the second uncompensated analyte measurement at the first prior reference time;

determining a second scaled rate-of-change by multiplying a second weighting coefficient and a second rate-of-change, the second rate-of-change computed between the first uncompensated analyte measurement at the first initial reference time to the third uncompensated analyte measurement at the second prior reference time; and

calculating a first filter lag-compensated point measurement based on the first uncompensated analyte measurement, the first scaled rate-of-change, and the second scaled rate-of-change; and

determining, by the analyte monitoring device, an estimated blood analyte level of the subject at the first initial reference time by using the first filter lag-compensated point measurement calculated based on the first uncompensated analyte measurement sensed in the interstitial fluid, wherein the estimated blood analyte level compensates for the lag corresponding to analyte measurements sensed in the interstitial fluid relative to measurements sensed in blood;

wherein the analyte monitoring device is configured to display a representation of the estimated blood analyte level at the first initial reference time.

18 . A method of determining a level of glucose in a bodily fluid with a glucose monitoring system comprising an in vivo sensor and a glucose monitoring device, which monitor glucose over a period of time, the method comprising:

determining, by one or more processors of the glucose monitoring system, a combination of time delays, the combination of time delays including a first time delay and a second time delay, wherein determining the combination of time delays comprises:

defining a search space;

evaluating a plurality of candidate combination of time delays within the search space based on an evaluation function; and

selecting, based on the evaluation function, the first time delay and the second time delay for the combination of time delays;

sensing, by the in vivo sensor that is in contact with interstitial fluid of a subject, a first uncompensated glucose measurement, a second uncompensated glucose measurement, a third uncompensated glucose measurement, wherein the first uncompensated glucose measurement is associated with a lag corresponding to glucose measurements sensed in the interstitial fluid relative to measurements sensed in blood, wherein the first uncompensated glucose measurement is sensed at a first initial reference time, wherein the second glucose measurement and the third glucose measurement are sensed at prior time points corresponding to a first prior reference time for the second glucose measurement and a second prior reference time for the third glucose measurement, wherein the first prior reference time corresponds to the first time delay and the second prior reference time corresponds to the second time delay;

receiving, by the glucose monitoring device, the first uncompensated glucose measurement, the second uncompensated glucose measure, and the third uncompensated glucose measurement;

applying, by the glucose monitoring device, a first glucose point measurement filter by:

determining a first scaled rate-of-change by multiplying a first weighting coefficient and a first rate-of-change, the first rate-of-change computed between the first uncompensated glucose measurement at the first initial reference time to the second uncompensated glucose measurement at the first prior reference time; and

determining a second scaled rate-of-change by multiplying a second weighting coefficient and a second rate-of-change, the second rate-of-change computed between the first uncompensated glucose measurement at the first initial reference time to the third uncompensated glucose measurement at the second prior reference time; and

calculating a first filter lag-compensated point measurement based on the first uncompensated glucose measurement, the first scaled rate-of-change, and the second scaled rate-of-change; and

determining, by the glucose monitoring device, an estimated blood glucose level of the subject at the first initial reference time by using the first filter lag-compensated point measurement calculated based on the first uncompensated glucose measurement sensed in the interstitial fluid, wherein the estimated blood glucose level compensates for the lag corresponding to glucose measurements sensed in the interstitial fluid relative to measurements sensed in blood;

displaying, by the glucose monitoring device, a representation of the estimated blood glucose level at the first initial reference time.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2020
From: BUDIMAN, ERWIN S.; LI, DAVID L.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 051533/0728 →
Continuity (4)
Continuation 15289776 · Oct 10, 2016
Continuation 13869813 · Apr 24, 2013
Provisional Application 61637748 · Apr 24, 2012
Related Publication 20200146634A1 · May 14, 2020
References Cited (321)
US 4545382A · Higgins et al. · 1985 [cited by applicant]
US 4650547A · Gough · 1987 [cited by applicant]
US 4703756A · Gough et al. · 1987 [cited by applicant]
US 4711245A · Higgins et al. · 1987 [cited by applicant]
US 4750496A · Reinhart et al. · 1988 [cited by applicant]
US 5034112A · Murase et al. · 1991 [cited by applicant]
US 5089112A · Skotheim et al. · 1992 [cited by applicant]
US 5145381A · Volz · 1992 [cited by applicant]
US 5262035A · Gregg et al. · 1993 [cited by applicant]
US 5262305A · Heller et al. · 1993 [cited by applicant]
US 5264103A · Yoshioka et al. · 1993 [cited by applicant]
US 5264104A · Gregg et al. · 1993 [cited by applicant]
US 5320725A · Gregg et al. · 1994 [cited by applicant]
US 5352351A · White et al. · 1994 [cited by applicant]
US 5356786A · Heller et al. · 1994 [cited by applicant]
US 5390671A · Lord et al. · 1995 [cited by applicant]
US 5391250A · Cheney, II et al. · 1995 [cited by applicant]
US 5411647A · Johnson et al. · 1995 [cited by applicant]
US 5497772A · Schulman et al. · 1996 [cited by applicant]
US 5509410A · Hill et al. · 1996 [cited by applicant]
US 5593852A · Heller et al. · 1997 [cited by applicant]
US 5601435A · Quy · 1997 [cited by applicant]
US 5628890A · Carter et al. · 1997 [cited by applicant]
US 5695623A · Michel et al. · 1997 [cited by applicant]
US 5786439A · Van Antwerp et al. · 1998 [cited by applicant]
US 5791344A · Schulman et al. · 1998 [cited by applicant]
US 5820551A · Hill et al. · 1998 [cited by applicant]
US 5822715A · Worthington et al. · 1998 [cited by applicant]
US 5863400A · Drummond et al. · 1999 [cited by applicant]
US 5899855A · Brown · 1999 [cited by applicant]
US 5918603A · Brown · 1999 [cited by applicant]
US 6001067A · Shults et al. · 1999 [cited by applicant]
US 6071391A · Gotoh et al. · 2000 [cited by applicant]
US 6103033A · Say et al. · 2000 [cited by applicant]
US 6121009A · Heller et al. · 2000 [cited by applicant]
US 6134461A · Say et al. · 2000 [cited by applicant]
US 6144837A · Quy · 2000 [cited by applicant]
US 6161095A · Brown · 2000 [cited by applicant]
US 6168957B1 · Matzinger et al. · 2001 [cited by applicant]
US 6175752B1 · Say et al. · 2001 [cited by applicant]
US 6212417B1 · Ikeda et al. · 2001 [cited by applicant]
US 6237394B1 · Harris et al. · 2001 [cited by applicant]
US 6270455B1 · Brown · 2001 [cited by applicant]
US 6275717B1 · Gross et al. · 2001 [cited by applicant]
US 6284478B1 · Heller et al. · 2001 [cited by applicant]
US 6360888B1 · McIvor et al. · 2002 [cited by applicant]
US 6366794B1 · Moussy et al. · 2002 [cited by applicant]
US 6377894B1 · Deweese et al. · 2002 [cited by applicant]
US 6400974B1 · Lesho · 2002 [cited by applicant]
US 6424847B1 · Mastrototaro et al. · 2002 [cited by applicant]
US 6475372B1 · Ohara et al. · 2002 [cited by applicant]
US 6475750B1 · Han et al. · 2002 [cited by applicant]
US 6503381B1 · Gotoh et al. · 2003 [cited by applicant]
US 6514460B1 · Fendrock · 2003 [cited by applicant]
US 6514718B2 · Heller et al. · 2003 [cited by applicant]
US 6522903B1 · Berman et al. · 2003 [cited by applicant]
US 6540891B1 · Stewart et al. · 2003 [cited by applicant]
US 6558321B1 · Burd et al. · 2003 [cited by applicant]
US 6560471B1 · Heller et al. · 2003 [cited by applicant]
US 6565509B1 · Plante et al. · 2003 [cited by applicant]
US 6579690B1 · Bonnecaze et al. · 2003 [cited by applicant]
US 6587704B1 · Fine et al. · 2003 [cited by applicant]
US 6600997B2 · Deweese et al. · 2003 [cited by applicant]
US 6605200B1 · Mao et al. · 2003 [cited by applicant]
US 6605201B1 · Mao et al. · 2003 [cited by applicant]
US 6654625B1 · Say et al. · 2003 [cited by applicant]
US 6676816B2 · Mao et al. · 2004 [cited by applicant]
US 6730200B1 · Stewart et al. · 2004 [cited by applicant]
US 6736957B1 · Forrow et al. · 2004 [cited by applicant]
US 6746582B2 · Heller et al. · 2004 [cited by applicant]
US 6764581B1 · Forrow et al. · 2004 [cited by applicant]
US 6809653B1 · Mann et al. · 2004 [cited by applicant]
US 6835553B2 · Han et al. · 2004 [cited by applicant]
US 6850859B1 · Schuh · 2005 [cited by applicant]
US 6881551B2 · Heller et al. · 2005 [cited by applicant]
US 6893545B2 · Gotoh et al. · 2005 [cited by applicant]
US 6931327B2 · Goode, Jr. et al. · 2005 [cited by applicant]
US 6932894B2 · Mao et al. · 2005 [cited by applicant]
US 6990366B2 · Say et al. · 2006 [cited by applicant]
US 7090756B2 · Mao et al. · 2006 [cited by applicant]
US 7167818B2 · Brown · 2007 [cited by applicant]
US 7220387B2 · Flaherty et al. · 2007 [cited by applicant]
US 7299082B2 · Feldman et al. · 2007 [cited by applicant]
US 7491303B2 · Sakata et al. · 2009 [cited by applicant]
US 7643798B2 · Ljung · 2010 [cited by applicant]
US 7811231B2 · Jin et al. · 2010 [cited by applicant]
US 7822557B2 · Chen et al. · 2010 [cited by applicant]
US 8103471B2 · Hayter · 2012 [cited by applicant]
US 8106780B2 · Goodnow et al. · 2012 [cited by applicant]
US 8396670B2 · St-Pierre · 2013 [cited by applicant]
US 10827954B2 · Hoss et al. · 2020 [cited by applicant]
US 10945647B2 · Mazza et al. · 2021 [cited by applicant]
US 10973443B2 · Funderburk et al. · 2021 [cited by applicant]
US 10980461B2 · Simpson et al. · 2021 [cited by applicant]
US 11000216B2 · Curry et al. · 2021 [cited by applicant]
US 11020031B1 · Simpson et al. · 2021 [cited by applicant]
US 11064917B2 · Simpson et al. · 2021 [cited by applicant]
US 20020010390A1 · Guice et al. · 2002 [cited by applicant]
US 20020043651A1 · Darrow et al. · 2002 [cited by applicant]
US 20020161288A1 · Shin et al. · 2002 [cited by applicant]
US 20020177764A1 · Sohrab · 2002 [cited by applicant]
US 20030003524A1 · Taniike et al. · 2003 [cited by applicant]
US 20030028184A1 · Lebel et al. · 2003 [cited by applicant]
US 20030076082A1 · Morgan et al. · 2003 [cited by applicant]
US 20040018486A1 · Dunn et al. · 2004 [cited by applicant]
US 20040022438A1 · Hibbard · 2004 [cited by applicant]
US 20040106858A1 · Say et al. · 2004 [cited by applicant]
US 20040127777A1 · Ruchti et al. · 2004 [cited by applicant]
US 20040244151A1 · Sakata et al. · 2004 [cited by applicant]
US 20050004439A1 · Shin et al. · 2005 [cited by applicant]
US 20050027180A1 · Goode et al. · 2005 [cited by applicant]
US 20050059871A1 · Gough et al. · 2005 [cited by applicant]
US 20050069892A1 · Iyengar et al. · 2005 [cited by applicant]
US 20050143636A1 · Zhang et al. · 2005 [cited by applicant]
US 20050151976A1 · Toma · 2005 [cited by applicant]
US 20050215871A1 · Feldman et al. · 2005 [cited by applicant]
US 20050239154A1 · Feldman et al. · 2005 [cited by applicant]
US 20050245799A1 · Brauker et al. · 2005 [cited by applicant]
US 20050283208A1 · Von Arx et al. · 2005 [cited by applicant]
US 20060020187A1 · Brister et al. · 2006 [cited by applicant]
US 20060094944A1 · Chuang · 2006 [cited by applicant]
US 20060094945A1 · Barman et al. · 2006 [cited by applicant]
US 20060142651A1 · Brister et al. · 2006 [cited by applicant]
US 20060258929A1 · Goode, Jr. et al. · 2006 [cited by applicant]
US 20060258959A1 · Sode · 2006 [cited by applicant]
US 20060281985A1 · Ward et al. · 2006 [cited by applicant]
US 20060293576A1 · Van Antwerp et al. · 2006 [cited by applicant]
US 20070095661A1 · Wang et al. · 2007 [cited by applicant]
US 20070249922A1 · Peyser et al. · 2007 [cited by applicant]
US 20070255116A1 · Mehta et al. · 2007 [cited by applicant]
US 20070299617A1 · Willis · 2007 [cited by applicant]
US 20080172205A1 · Breton et al. · 2008 [cited by applicant]
US 20080177164A1 · Heller et al. · 2008 [cited by applicant]
US 20080179187A1 · Ouyang et al. · 2008 [cited by applicant]
US 20080287763A1 · Hayter · 2008 [cited by examiner]
US 20080312842A1 · Hayter et al. · 2008 [cited by applicant]
US 20090054737A1 · Magar et al. · 2009 [cited by applicant]
US 20090076360A1 · Brister et al. · 2009 [cited by applicant]
US 20090102678A1 · Mazza et al. · 2009 [cited by applicant]
US 20090143659A1 · Li et al. · 2009 [cited by applicant]
US 20090163789A1 · Say et al. · 2009 [cited by applicant]
US 20090178459A1 · Li et al. · 2009 [cited by applicant]
US 20090192380A1 · Shariati et al. · 2009 [cited by applicant]
US 20090192745A1 · Kamath · 2009 [cited by examiner]
US 20090198118A1 · Hayter et al. · 2009 [cited by applicant]
US 20090247857A1 · Harper et al. · 2009 [cited by applicant]
US 20090291634A1 · Saarisalo · 2009 [cited by applicant]
US 20100057042A1 · Hayter · 2010 [cited by applicant]
US 20100198034A1 · Thomas et al. · 2010 [cited by applicant]
US 20100213057A1 · Feldman et al. · 2010 [cited by applicant]
US 20100230285A1 · Hoss et al. · 2010 [cited by applicant]
US 20100274515A1 · Hoss et al. · 2010 [cited by applicant]
US 20100324392A1 · Yee et al. · 2010 [cited by applicant]
US 20100326842A1 · Mazza et al. · 2010 [cited by applicant]
US 20110058485A1 · Sloan · 2011 [cited by applicant]
US 20110120865A1 · Bommakanti et al. · 2011 [cited by applicant]
US 20110124993A1 · Bommakanti et al. · 2011 [cited by applicant]
US 20110124994A1 · Bommakanti et al. · 2011 [cited by applicant]
US 20110126188A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110193704A1 · Harper et al. · 2011 [cited by applicant]
US 20110210830A1 · Talty et al. · 2011 [cited by applicant]
US 20110213225A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110256024A1 · Cole et al. · 2011 [cited by applicant]
US 20110257495A1 · Hoss et al. · 2011 [cited by applicant]
US 20110270062A1 · Goode et al. · 2011 [cited by applicant]
US 20120078071A1 · Bohm et al. · 2012 [cited by applicant]
US 20120084053A1 · Yuen et al. · 2012 [cited by applicant]
US 20120108935A1 · Liang · 2012 [cited by examiner]
US 20120157801A1 · Hoss et al. · 2012 [cited by applicant]
US 20120233679A1 · Shedrinsky · 2012 [cited by applicant]
US 20120238851A1 · Kamen et al. · 2012 [cited by applicant]
US 20120245447A1 · Karan et al. · 2012 [cited by applicant]
US 20120255875A1 · Vicente et al. · 2012 [cited by applicant]
US 20120309302A1 · Buhot · 2012 [cited by applicant]
US 20120323098A1 · Moein et al. · 2012 [cited by applicant]
US 20150005601A1 · Hoss et al. · 2015 [cited by applicant]
US 20190274598A1 · Scott et al. · 2019 [cited by applicant]
EP 1391728 · 2004 [cited by applicant]
EP 1413879 · 2012 [cited by applicant]
EP 2498196 · 2012 [cited by applicant]
EP 3575796 · 2019 [cited by applicant]
WO WO9718639 · 1997 [cited by applicant]
WO WO0049941 · 2000 [cited by applicant]
WO WO02058537 · 2002 [cited by applicant]
WO WO03012422 · 2003 [cited by applicant]
WO WO03032411 · 2003 [cited by applicant]
WO WO03094714 · 2003 [cited by applicant]
WO WO2005011489 · 2005 [cited by applicant]
WO WO2005041766 · 2005 [cited by applicant]
WO WO2005070287 · 2005 [cited by applicant]
WO WO2008021913 · 2008 [cited by applicant]
WO WO2008088490 · 2008 [cited by applicant]
WO WO2010039744 · 2010 [cited by applicant]
WO WO2010077328 · 2010 [cited by applicant]
WO WO2010099507 · 2010 [cited by applicant]
WO WO2011011643 · 2011 [cited by applicant]
WO WO2012142502 · 2012 [cited by applicant]
WO WO2013019225 · 2013 [cited by applicant]
Bequette, B. W. Continuous Glucose Monitoring: Real-Time Algorithms for Calibration, Filtering, and Alarms. Journal of Diabetes Science and Technology 2010, 4 (2), 404-418. [cited by examiner]
Keenan, D. B .; Mastrototaro, J. J .; Voskanyan, G .; Steil, G. M. Delays in Minimally Invasive Continuous Glucose Monitoring Devices : A Review of Current Technology. Journal of Diabetes Science and Technology 2009, 3 … [cited by examiner]
Abel, et al., “Biosensors for in vivo glucose measurement: can we cross the experimental stage”, Biosensors and Bioelectronics, 17:1059-1070 (2002). [cited by applicant]
Alcock, et al., “Continuous Analyte Monitoring to Aid Clinical Practice”, IEEE Engineering in Medicine and Biology, pp. 319-325 (1994). [cited by applicant]
Bard, et al., Electrochemical Methods, Fundamentals and Applications, pp. 174-175 (1980). [cited by applicant]
Bequette, “Continuous Glucose Monitoring: Real Time Algorithms for Calibration, Filtering, and Alarms”, Journal of Diabetes Science and Technology, 4(2):404-418 (2010). [cited by applicant]
“Blood glucose monitoring” retrieved from “https://web.archive.org/web/20111215063153/http://en.wikipedia.org/wiki/Blood_glucose_monitoring” on Aug. 1, 2021, 6 pages. [cited by applicant]
Cengiz, et al., “A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring”, Diabetes Technology & Therapeutics, 11(1):S-11-S16 (2009). [cited by applicant]
Chen, et al., “Glucose microbiosensor based on alumina sol gel matrix/eletropolymerized composite membrane”, Biosensors and Bioelectronics, 17:1005-1013 (2002). [cited by applicant]
Chen, et al., “Defining the Period of Recovery of the Glucose Concentration after its Local Perturbation by the Implantation of a Miniature Sensor”, Clin Chem Lab Med, 40(8):786-789 (2002). [cited by applicant]
Chen, et al., “In Situ Assembled Mass-Transport Controlling Micromembranes and Their Application in Implanted Amperometric Glucose Sensors”, Analytical Chemistry, 72(16):3757-3763 (2000). [cited by applicant]
Chen, et al., “In vivo Glucose Monitoring with Miniature “Wired” Glucose Oxidase Electrodes”, Analytical Sciences, 17:1297-1300 (2001). [cited by applicant]
Choleau et al., “Calibration of a subcutaneous amperometric glucose sensor—Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current,” Biosensors and Bioelectronics 17… [cited by applicant]
Chung, “In vitro Evaluation of the Continuous Monitoring Glucose Sensors with Perfluorinated Tetrafluoroethylene Coatings”, Bull. Korean Chem. Soc., 24(4):514-516 (2003). [cited by applicant]
Csöregi et al., “Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode,” Anal. Chem., 66, 3131-3138 (1994). [cited by applicant]
De Block, et al., “Minimally-Invasive and Non-Invasive Continuous Glucose Monitoring Systems: Indications, Advantages, Limitations and Clinical Aspects”, Current Diabetes Reviews, 4:159-168 (2008). [cited by applicant]
Decuir, “Bluetooth 4.0:Low Energy”, Standards Architect, CSR Technology, Councilor, Bluetooth Architecture Review Board, IEEE Region 6 Northwest Area Chair, 104 pages (2012). [cited by applicant]
Dementyev, et al., “Power Consumption Analysis of Bluetooth Low Energy, ZigBee and ANT Sensor Nodes in a Cyclic Sleep Scenario”, IEEE International Wireless Symposium (IWS), 5 pages (2013). [cited by applicant]
Facchinetti, et al., “Enhanced Accuracy of Continuous Glucose Monitoring by Online Extended Kalman Filtering”, Diabetes Technology & Therapeutics, 12(5):353-363 (2010). [cited by applicant]
Feldman, et al., “A Continuous Glucose Sensor Based on Wired EnzymeIM Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, 5(5):769-779 (2003). [cited by applicant]
Fisher, “Fundamentals of Glucose Sensors,” Diabetic Medicine, 8: 309-321 (1991). [cited by applicant]
Fraser, “An Introduction to in vivo Biosensing: Progress and Problems”, Biosensors in the Body: Continuous in vivo Monitoring, pp. 1-56 (1997). [cited by applicant]
FreeStyle Navigator Continuous Glucose Monitoring System, Summary of Safety and Effectiveness Data in support of Pre-Market Approval (PMA) No. P050020, Abbott Diabetes Care, 27 pages (2008). [cited by applicant]
FreeStyle Navigator Continuous Glucose Monitoring System, User Guide, Abbott Diabetes Care Inc., 195 pages (2008). [cited by applicant]
Frost, et al., “Implantable chemical sensors for real-time clinical monitoring: progress and challenges”, Current Opinion in Chemical Biology, 6:633-641 (2002). [cited by applicant]
Gerritsen, et al., “Subcutaneously implantable glucose sensors in patients with diabetes mellitus; still many problems”, Dutch Journal of Medicine, 146(28):1313-1316 (2002) (with English Machine Translation). [cited by applicant]
Guardian® REAL-Time, Continuous Glucose Monitoring System, User Guide, Medtronic MiniMed, Inc., 181 pages (2006). [cited by applicant]
Guardian® RT, Continuous Glucose Monitoring System, REF MMT-7900, User Guide, Medtronic MiniMed, 128 pages (2005). [cited by applicant]
Heinemann, “Continuous Glucose Monitoring by Means of the Microdialysis Technique: Underlying Fundamental Aspects”, Diabetes Technology & Therapeutics, 5(4):545-561 (2003). [cited by applicant]
Heise, et al., “Hypoglycemia Warning Signal and Glucose Sensors: Requirements and Concepts”, Diabetes Technology & Therapeutics, 5(4):563-571 (2003). [cited by applicant]
Heller, “Implanted Electrochemical Glucose Sensors for the Management of Diabetes”, Annu. Rev. Biomed. Eng., 01:153-175 (1999). [cited by applicant]
Heller, et al., “Electrochemical Glucose Sensors and Their Applications in Diabetes Management”, Chemical Reviews, 108(7):2482-2505 (2008). [cited by applicant]
“In Vivo Glucose Sensing”, Chemical Analysis, A Series of Monographs on Analytical Chemistry and its Applications, vol. 174, 466 pages (2010). [cited by applicant]
Jiménez, et al., “Glucose sensor based on an amperometric microelectrode with a photopolymerizable enzyme membrane”, Sensors and Actuators B, 26-27:421-424 (1995). [cited by applicant]
Johnson et al., “Reduction of Electrooxidizable Interferent Effects: Optimization of the Applied Potential for Amperometric Glucose Sensors,” Electroanalysis, 6, 321-326 (1991). [cited by applicant]
Klonoff, “A Review of Continuous Glucose Monitoring Technology”, Diabetes Technology & Therapeutics, 7(5):770-775 (2005). [cited by applicant]
Klonoff, “Continuous Glucose Monitoring: Roadmap for 21st century diabetes therapy”, Diabetes Care, 28(5):1231-1239 (2005). [cited by applicant]
Knobbe, et al., “The Extended Kalman Filter for Continuous Glucose Monitoring”, Diabetes Technology & Therapeutics, 7(1): 15-27 (2005). [cited by applicant]
Koudelka, et al., “In-vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors”, Biosensors & Bioelectronics, 6:31-36 (1991). [cited by applicant]
Koudelka-Hep, “Electrochemical Sensors for in vivo Glucose Sensing”, Biosensors in the Body: Continuous in vivo Monitoring, pp. 57-77 (1997). [cited by applicant]
Kuure-Kinsey, et al., “A Dual-Rate Kalman Filter for Continuous Glucose Monitoring”, Proceedings of the 28th IEEE, EMBS Annual International Conference, pp. 63-66 (2006). [cited by applicant]
Kvist, et al., “Recent Advances in Continuous Glucose Monitoring: Biocompatibility of Glucose Sensors for Implantation in Subcutis”, Journal of Diabetes Science and Technology, 1(5):746-752 (2007). [cited by applicant]
Lodwig, et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria”, Diabetes Technology & Therapeutics, 5(4):573-587 (2003). [cited by applicant]
Ming Li, et al., “Implantable Electrochemical Sensors for Biomedical and Clinical Applications: Progress, Problems, and Future Possibilities”, Current Medicinal Chemistry, 14:937-951 (2007). [cited by applicant]
Moatti-Sirat, et al., “Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor”, Biosensors and Bioelectronics, 7(5):345-352 (1992). [cited by applicant]
Morak, et al., “Design and Evaluation of a Telemonitoring Concept Based on NFC- Enabled Mobile Phones and Sensor Devices”, IEEE Transactions on Information Technology in Biomedicine, 16(1):17-23 (2012). [cited by applicant]
Movassaghi, et al., “Wireless Technologies for Body Area Networks: Characteristics and Challenges”, IEEE, International Symposium on Communications and Information Technologies (ISCIT), pp. 42-47 (2012). [cited by applicant]
“Near field communication” retrieved from “http://en.wikipedia.org/w/index.php?title=Near_field_communication&oldid=543740757” on Jun. 27, 2014, 14 pages. [cited by applicant]
Nishida, et al., “Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate”, Medical Progress th… [cited by applicant]
Onuki, et al., “A Review of the Biocompatibility of Implantable Devices: Current Challenges to Overcome Foreign Body Response”, Journal of Diabetes Science and Technology, 2(6):1003-1015 (2008). [cited by applicant]
Palerm, et al., “Hypoglycemia Prediction and Detection Using Optimal Estimation”, Diabetes Technology & Therapeutics, 7(1):3-14 (2005). [cited by applicant]
Poitout, et al., “Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination”, Biosensors & Bioelectronics, 7:587-592 (1992). [cited by applicant]
Rebrin, et al., “Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring”, American Journal of Physiology-Endocrinology and Metabolism, 277(3):E561-E571 (1999). [cited by applicant]
Renard, “Implantable glucose sensors for diabetes monitoring”, Min Invas Ther & Allied Technol, 13(2):78-86 (2004). [cited by applicant]
Rhodes, et al., “Prediction of Pocket-Portable and Implantable Glucose Enzyme Electrode Performance from Combined Species Permeability and Digital Simulation Analysis”, Analytical Chemistry, 66(9):1520-1529 (1994). [cited by applicant]
Robert, “Continuous Monitoring of Blood Glucose”, Horm Res 57(suppl 1):81-84 (2002). [cited by applicant]
Schlosser, et al., “Biocompatibility of Active Implantable Devices”, Biosensors in the Body: Continuous in vivo Monitoring, pp. 139-170 (1997). [cited by applicant]
Schmidt, et al., “Calibration of a wearable glucose sensor”, The International Journal of Artificial Organs, 15(1):55-61 (1992). [cited by applicant]
Schmidtke et al., “Accuracy of the One-Point in Vivo Calibration of “Wired” Glucose Oxidase Electrodes Implanted in Jugular Veins of Rats in Periods of Rapid Rise and Decline of the Glucose Concentration,” Anal. Chem., … [cited by applicant]
Specification of the Bluetooth System, Experience More, Specification vol. 0, Covered Core Package Version: 4.0, 2 302 pages (2010). [cited by applicant]
Tierney, et al., “Effect of Acetaminophen on the Accuracy of Glucose Measurements Obtained with the GlucoWatch Biographer”, Diabetes Technology & Therapeutics, 2(2):199-207 (2000). [cited by applicant]
Townsend, et al., “Getting Started with Bluetooth Low Energy [Book]”, O'Reilly, retrieved from https://www.oreilly.com/library/view/getting-started-with/9781491900550/ch01.html on May 5, 2020, 26 pages. [cited by applicant]
Velho, et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomed. Biochim. Acta, vol. 48, pp. 957-964 (1989). [cited by applicant]
Voskerician, et al., “Sensor Biocompatibility and Biofouling in Real-Time Monitoring”, Wiley Encyclopedia of Biomedical Engineering, (John Wiley & Sons, Inc.), pp. 1-19 (2006). [cited by applicant]
Ward, “A Review of the Foreign-body Response to Subcutaneously-implanted Devices: The Role of Macrophages and Cytokines in Biofouling and Fibrosis”, Journal of Diabetes Science and Technology, 2(5):768-777 (2008). [cited by applicant]
Ward, et al., “A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation”, Biosensors & Bioelectronics, 17:181-189 (2002). [cited by applicant]
Yang, et al., “Glucose Biosensors Based on Oxygen Electrode with Sandwich-Type Membranes”, Annals of Biomedical Engineering, 23:833-839 (1995). [cited by applicant]
Yang, et al., “Glucose Biosensors with Enzyme Entrapped in Polymer Coating”, Biomedical Instrumentation & Technology, 29(2):125-133 (1995). [cited by applicant]
Chen, et al., “A novel fault-tolerant sensor system for sensor drift compensation”, Sensors and Actuators, A 147:623-632 (2008). [cited by applicant]
Gerritsen, et al., “Performance of subcutaneously implanted glucose sensors for continuous monitoring”, The Netherlands Journal of Medicine, 54:167-179 (1999). [cited by applicant]
Kalivas, et al., “Compensation for Drift and Interferences in Multicomponent Analysis”, Laboratory for Chemometrics, Department of Chemistry, University of Washington, 38 pages (1982). [cited by applicant]
Thévenot, et al., “Electrochemical Biosensors: Recommended Definitions and Classification (Technical Report)”, Pure Appl. Chem. 71(12):2333-2348 (1999). [cited by applicant]
U.S. Appl. No. 12/842,013 Office Action mailed Aug. 26, 2015. [cited by applicant]
U.S. Appl. No. 12/842,013 Office Action mailed Mar. 23, 2016. [cited by applicant]
U.S. Appl. No. 12/842,013 Office Action mailed Nov. 6, 2014. [cited by applicant]
Walt, et al., “The chemistry of enzyme and protein immobilization with glutaraldehyde”, Trends in Analytical Chemistry, 13(10):425-430 (1994). [cited by applicant]
Zhang, “Investigations of potentially implantable glucose sensors”, University of Kansas, 24 pages (1991). [cited by applicant]
Atanasov, et al., “Implantation of a refillable glucose monitoring-telemetry device”, Biosensors & Bioelectronics, 12(7):669-680 (1997). [cited by applicant]
Bindra, “Development of potentially implantable glucose sensors”, The University of Arizona, 227 pages (1990). [cited by applicant]
FreeStyle Navigator Continuous Glucose Monitoring System, User's Guide, Abbott Diabetes Care Inc., 38 pages (2008). [cited by applicant]
Guardian® REAL-Time, Continuous Glucose Monitoring System, User Guide, Medtronic MiniMed, Inc., 184 pages (2006). [cited by applicant]
Kerner, et al., The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma, Biosensors & Bioelectronics, 8:473-482 (1993). [cited by applicant]
Koschinsky, et al., “Sensors for glucose monitoring: technical and clinical aspects”, Diabetes/Metabolism Research and Reviews, 17:113-123 (2001). [cited by applicant]
Koschwanez, et al., “In vitro, in vivo and post explantation testing of glucose-detecting biosensors: Current methods and recommendations”, Biomaterials, 28:3687-3703 (2007). [cited by applicant]
Moussy, et al. “Performance of Subcutaneously Implanted Needle-Type Glucose Sensors Employing a Novel Trilayer Coating”, Anal. Chem., 65:2072-2077 (1993). [cited by applicant]
Pickup, et al., “In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring”, BMJ, 319, pp. 1-4 (1999). [cited by applicant]
Pickup, et al., “Responses and calibration of amperometric glucose sensors implanted in the subcutaneous tissue of man”, Acta Diabetol, 30:143-148 (1993). [cited by applicant]
Ward, et al., “Rise in background current over time in a subcutaneous glucose sensor in the rabbit: relevance to calibration and accuracy”, Biosensors & Bioelectronics, 15:53-61 (2000). [cited by applicant]
Wilson, et al., “Biosensors for real-time in vivo measurements”, Biosensors and Bioelectronics, 20:2388-2403 (2005). [cited by applicant]
Wisniewski, et al., “Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats”, Am J Physiol Endocrinol Metab, 282:E1316-E1323 (2002). [cited by applicant]
Choleau, et al., “Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients Part 2. Superiority of the one-point calibration method”, Biosensors and Bioelectronics, 17:647-654 (… [cited by applicant]
File History for U.S. Appl. No. 60/687,199, filed Jun. 2, 2004, Ward et al. [cited by applicant]
File History for U.S. Appl. No. 61/155,889, filed Feb. 26, 2009, Hoss et al. [cited by applicant]
Hanson, K. et al., “Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems”, Journal of Diabetes Science and Technology, 2024, pp. 1-10. [cited by applicant]
Dock, E. et al., “Multivariate data analysis of dynamic amperometric biosensor responses from binary analyte mixtures—application of sensitivity correction algorithms”, Talanta, 65, 2005, pp. 298-305. [cited by applicant]
FreeStyle Navigator Continuous Glucose Monitoring System, Dept of Health & Human Services, Food and Drug Administration, Mar. 12, 2008, 8 pages. [cited by applicant]
Hoss, U. et al., “Continuous Glucose Monitoring in Subcutaneous Tissue Using Factory-Calibrated Sensors: A Pilot Study”, 2010, vol. 12, No. 8, pp. 591-597. [cited by applicant]
Hoss, U. et al., “Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology”, Diabetes Technology & Therapeutics, 2017, vol. 19, Suppl. 2, pp. S-44-S-50. [cited by applicant]
Abbott Press Release—“Abbott Receives CE Mark for FreeStyle® Libre, A Revolutionary Glucose Monitoring System for People with Diabetes” retrieved from https://abbott.mediaroom.com/2014-09-03-Abbott-Receives-CE-Mark-for-… [cited by applicant]
Abbott Press Release—“Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, A Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with their Patients” retrieved from https://abbott.… [cited by applicant]
Abbott Press Release—“Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S.” retrieved from https://abbott.mediaroom.com/2018-07-27-Abbotts-FreeStyle-R-Libre-14-Day-Flash-Glucose-Monitori… [cited by applicant]
ANZHSN, National Horizon Scanning Unit Horizon Scanning Report, “GlucoWatch® G2 Biographer for the non-invasive monitoring of glucose levels”, 46 pages, May 2004. [cited by applicant]
Cather, CGM Frustrations Survey dated June 2020, 37 pages in [cited by applicant]
Clinical Trials, Competitor and Ecosystem Players dated Jun. 25, 2020, 29 pages in [cited by applicant]
Declaration of Dr. Anthony Edward Cass in Support of Petition for Inter Partes Review of U.S. Pat. No. 11,020,031 in [cited by applicant]
Declaration of Karl R. Leinsing, MSME, PE, in Support of Abbott's Motion for Summary Judgment dated May 19, 2023, 81 pages in [cited by applicant]
Effectiveness and Safety Study of the DexComTM G4 Continuous Glucose Monitoring System, DexCom, Inc., U.S. National Library of Medicine, ClinicalTrials.gov Identifier: NCT01111370, 4 pages (2017). [cited by applicant]
E-mail Communication from Christopher M. Dougherty regarding Bi Monthly Global Commercial Insights Meeting dated December 17, 2019, 69 pages in [cited by applicant]
Design U.S. Appl. No. 29/101,218, filed Feb. 25, 1999, 11 pages. [cited by applicant]
File Wrapper for U.S. Pat. No. 11,020,031 issued Jun. 1, 2021, 1058 pages. [cited by applicant]
FreeStyle Libre 2 HCP Pulse, Mar. 2021 Report, dated Mar. 1, 2021, 14 pages in [cited by applicant]
Godek, et al., Chapter 2, “The Macrophage in Wound Healing Surrounding Implanted Devices”, In Vivo Glucose Sensing, 36 pages (2010). [cited by applicant]
Gross, et al., “Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use”, Diabetes Technology & Therapeutics, vol. 2, No. 1, pp. 49-56 (2000). [cited by applicant]
Heller, “Integrated Medical Feedback Systems for Drug Delivery”, American Institute of Chemical Engineers Journal, vol. 51, No. 4, pp. 1054-1066 (2005). [cited by applicant]
Henning, Chapter 5, “Commercially Available Continuous Glucose Monitoring Systems”, In Vivo Glucose Sensing, 50 pages (2010). [cited by applicant]
Kovatchev, et al., “Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors”, Diabetes Care, vol. 27, No. 8, pp. 1922-1928 (2004). [cited by applicant]
Lesperance, et al., “Calibration of the Continuous Glucose Monitoring System for Transient Glucose Monitoring”, Diabetes Technology & Therapeutics, vol. 9, No. 2, pp. 183-190 (2007). [cited by applicant]
Project Status Update, Glucose Sensor Applicator Dexcom (project #2554), Design Concepts, Inc., 6 pages (2014). [cited by applicant]
Seagrove Partners, International Diabetes Device, 2022 Blue Book dated 2022, 143 pages. [cited by applicant]
In [cited by applicant]
Wisniewski, et al., “Characterization of implantable biosensor membrane biofouling”, Fresenius J Anal Chem, 366:611-621 (2000). [cited by applicant]
Extended European Search Report dated Apr. 4, 2025 in Application No. EP 25162245. [cited by applicant]
Vaseghi, “Wiener Filters” In: “Advanced Digital Signal Processing and Noise Reduction, Second Edition,” pp. 178-204 (2000). [cited by applicant]